A case of malignant calcifying epithelial odontogenic tumor.

Junji Nagahama, Keiji Sato, Hiroyuki Tanamachi, Kenji Kashima, Tsutomu Daa, Naomi Kaku, Iwao Nakayama, Shigeo YokoyamaThe Journal of the Japanese Society of Clinical Cytology 2002 · DOI

Calcifying Epithelial Odontogenic Tumor (CEOT), also known as a Pindborg tumor, is a rare, typically benign odontogenic neoplasm. However, rare malignant variants exist that pose significant diagnostic challenges. This report examines a case of malignant CEOT in a 56-year-old male, highlighting the difficulties in differentiating it from benign CEOT and squamous cell carcinoma (SCC) using cytology.

Case Progression and Metastasis

The patient initially presented with a CEOT in the left mandible. Despite surgical excision, the tumor recurred multiple times. By the third recurrence, histopathological analysis revealed features of malignancy, including increased mitotic activity (up to 21 per 10 high-power fields) and vascular invasion. Ultimately, the disease progressed to involve the right supraclavicular lymph nodes and the lungs, confirming its malignant nature.

Cytological Ambiguity

Fine-needle aspiration (FNA) cytology of the recurrent tumor showed a mix of small and large tumor cells. The cells exhibited high nucleus-to-cytoplasm (N/C) ratios, coarse chromatin, and prominent nucleoli.

Figure 2: FNA cytology showing tumor cells with significant nuclear atypia and prominent nucleoli, mimicking squamous cell carcinoma.

These features are highly suggestive of malignancy but are problematic because benign CEOT can also display significant cellular atypia. This "cytological trap" makes it nearly impossible to definitively diagnose malignancy based on FNA alone. The authors emphasize that the greatest danger is misdiagnosing a benign CEOT as a common squamous cell carcinoma, which might lead to unnecessarily radical treatment.

Histopathological Transformation

While the primary tumor exhibited the classic features of CEOT—squamous-like cells, amyloid deposits, and calcification—these hallmarks were largely lost in the later malignant recurrences.

Figure 5: Histopathology of the recurrent tumor showing solid sheets of pleomorphic cells with frequent mitoses, indicative of malignant transformation.

The transition from a well-defined benign tumor to an aggressive, poorly differentiated malignancy underscores the importance of longitudinal clinical monitoring. In this case, the loss of diagnostic markers like amyloid and calcification in later stages further complicated the pathological identification.

Conclusion

Distinguishing between benign and malignant CEOT via cytology remains extremely difficult. Because benign CEOT cells can look highly abnormal, there is currently no "smoking gun" in cytology that proves malignancy. In cases of suspected malignant CEOT, clinical evidence of recurrence and metastasis remains the most reliable indicator of malignancy.

Summary updated

BibTeX
@article{nagahama2002case,
  author = {Junji Nagahama and Keiji Sato and Hiroyuki Tanamachi and Kenji Kashima and Tsutomu Daa and Naomi Kaku and Iwao Nakayama and Shigeo Yokoyama},
  title = {{A case of malignant calcifying epithelial odontogenic tumor.}},
  journal = {The Journal of the Japanese Society of Clinical Cytology},
  year = {2002},
  doi = {10.5795/jjscc.41.406},
}
Figure